Dublin, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The "Electrosurgical Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global electrosurgical devices and equipment market was valued at about $3 billion in 2018 and is expected to grow to $3.98 billion at a CAGR of 7.3% through 2022.
Major players in the market are Bovie Medical Corporation, Johnson & Johnson Private Limited, B. Braun Melsungen, Medtronic, and Smith & Nephew.
North America was the largest region in the electrosurgical devices and equipment market in 2016. This region is expected to remain the largest during the next five years. The electrosurgical devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
Increasing prevalence rate of chronic diseases, contributed significantly to the growth of the electrosurgical devices and equipment market. The electrosurgical devices are used in the surgery of many life-threatening diseases such as skin cancer, small basal cell carcinomas, squamous cell carcinoma, wound surgery, skin surgery, non-cancerous moles, dentistry and others. There has been an increase in the number of skin diseases worldwide. For example, in the year 2019, according to one study conducted by the American Society of Clinical Oncology, around 2,000 people in the USA are diagnosed with merkel cell carcinoma each year and this number rapidly increasing from past decades.
According to WHO, the global burden of major chronic diseases currently accounts for 43% of all diseases and is set to rise to 60% by 2020. According to a United Nations' report on world population aging, during 2015-2030 globally the 60+ aged population is projected to grow by 56% to reach 1.4 billion. Growth of the aging population and rising chronic disease incidence will contribute to increased hospitalization. The increase in a patient the pool is expected to rise the demand for electrosurgical devices and equipment.
The high incidence of product recalls is one of the factors restraining the electrosurgical devices and equipment market growth. The medical device industry is seeing a significant spike in product recalls during recent years due to the defective devices, software issue, mislabeling issue and quality issues. The electrosurgical devices and equipment market is a minor part of medical device market and hence, product recall in electrosurgical market is quite often.
For example, in March 2019, Covidien, PLC, recalled its class 2 Covidien Force Traverse electrosurgical device due to bad sterile packaging. In May 2017, Zimmer Biomet, a medical device company recalled its class 1 SpF PLUS-Mini and SpF XL IIB Implantable Spinal Fusion Stimulators due to high levels of potential harmful chemicals which may be toxic to tissues and organs. In 2017, FDA Safety Communication notice was Magellan Diagnostics and LeadCare of Meridian Bioscience, Inc. for its LeadCare Testing Systems for giving inaccurate test results.
Electro surgery is the application of high-frequency electric current on biological tissue with the goal of creating. Technological advances have led to the development of modern ESUs that deliver medically useful thermal effect. This system is capable of continuously monitoring current and voltage, derive parameters such as power and tissue resistance, and analyze them. Depending on the desired treatment outcome, these devices can also keep the operating parameters constant or change them in a targeted manner through control and regulation. Electrosurgical equipment manufacturers should consider investing ESUs to increase market share in the market
The regulatory changes related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures and other regulatory changes are leading to increased costs of electrosurgical equipment product development and supply to healthcare services organizations. The GDPR regulation is an EU law on data protection and privacy of individuals residing the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. In 2018, According to a report by Ernst and Young, Fortune 500 companies are spending $7.8 billion to comply with GDPR regulations.
In the USA, U.S. Department of Health and Human Services and Center for Devices and Radiological Health are regulating electrosurgical devices under US FDA. There are two main ways that manufacturers can follow for premarket approval. One way consists of conducting clinical studies and submitting a premarket approval (PMA) application that includes evidence providing reasonable assurance that the device is safe and effective. The other way involves submitting a 510(k) notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA.
The FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The delays in product releases and additional costs incurred due to stringent approval processes puts strain to investments relating to electrosurgical equipment new product development resulting in potential loss of revenue.
Companies Mentioned
- Abaxis
- Adisseo France S.A.S.
- Alltech Inc.
- Archer Daniels Midland Company
- B. Braun Melsungen
- BASF SE
- Biostadt India Limited
- Bovie Medical Corporation
- BRF
- Cargill Incorporated
- CHS Inc.
- Delacon
- Diamond V
- Evonik Industries AG
- ForFarmers N.V.
- Hipro Animal Nutrtion
- Johnson & Johnson Private Limited
- Koninklijke DSM N.V
- Medtronic
- Muyuan Foodstuff
- Neovia
- Novozymes A/S
- Nutreco N.V.
- Phibro
- Purina Animal Nutrition
- Smith & Nephew
- Tyson Foods
- Wen's Food Group
- Zagro
- Zoetis Inc.
For more information about this report visit https://www.researchandmarkets.com/r/cwf4n4
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.